Warning letter
C R Supplements, LLC: warning letter of Apr 20, 2022
FDA warning letter 624651 · Office of Human and Animal Food Operations – West Division 6
Key facts
| Reference number | 624651 |
|---|---|
| Company | C R Supplements, LLC |
| Subject | Unapproved New Drugs/Misbranded |
| Issue date | Apr 20, 2022 |
| Posted date | May 3, 2022 |
| Issuing office | Office of Human and Animal Food Operations – West Division 6 |
| Product type | Food/Cosmetics |
| CFR sections cited | 101.36, 111, 111.55, 111.70, 111.73, 111.75, 111.95, 111.103, 111.105, 111.205, 111.210, 111.260 and 47 more |
| Inspection city | Kooskia |
| Inspection ZIP | 83539 |
| Inspection start date | Dec 6, 2021 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: